Загрузка...
CDK4 inhibition diminishes p53 activation by MDM2 antagonists
The genes encoding MDM2 and CDK4 are frequently co-amplified in sarcomas, and inhibitors to both targets are approved or clinically tested for therapy. However, we show that inhibitors of MDM2 and CDK4 antagonize each other in their cytotoxicity towards sarcoma cells. CDK4 inhibition attenuates the...
Сохранить в:
| Опубликовано в: : | Cell Death Dis |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6133967/ https://ncbi.nlm.nih.gov/pubmed/30206211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0968-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|